Magnolia Market Access at Evidence 360:
RWE, Pricing & Reimbursement Summit USA
June 8–9, 2026 | Hilton Garden Inn Camden Waterfront Philadelphia
Magnolia Market Access is heading to the 2026 Evidence 360 conference to join conversations shaping the future of real-world evidence, pricing, reimbursement, and access strategy.
As biopharma teams face rising expectations around evidence generation, payer relevance, pricing pressure, and policy-driven decision-making, the ability to connect evidence with access realities has never been more important. Magnolia Market Access helps manufacturers translate complex market dynamics into actionable strategies that support stronger value communication, smarter launch planning, and more confident access decisions.
Featured Session
The New Evidence Stack: Integrating RCTs, RWE, PROs, and Digital Data for Market Access Success
Beni Turner, Sr. Director of Value & Access Solutions, Magnolia Market Access
June 8 2026 | 10:00 AM – 10:30 AM
Meet with Our Team
Magnolia Market Access leaders will be onsite and available for one-on-one meetings throughout the conference: Whether you’re refining a value story, preparing for launch, or managing policy-driven change, our team is here to support.
Let’s Align Evidence with Access Realities
Magnolia Market Access partners with biopharma teams to build actionable, payer-relevant strategies rooted in data, policy awareness, and market dynamics. If you’re attending Evidence 360 and facing growing pressure around value, pricing, and reimbursement—let’s talk.
Beni Turner
Senior Director, Value & Access Solutions
Sean McGonigal
Vice President, Client Services
Request a Meeting
"*" indicates required fields